B. Vabres
14 Papers
9 Citations
B. Vabres is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Localisations orbitaires de la maladie de Rosai-Dorfman : série de trois cas consécutifs
TL;DR: Entite rare and meconnue, the maladie de Rosai-Dorfman presente cependant des localisations orbitaires non exceptionnelles, which illustre le polymorphisme de cette pathologie et ses difficultes diagnostiques et therapeutiques.
10
Greffe de membrane amniotique avec greffe conjonctivo-limbique dans le traitement des ptérygions récidivants, invasifs ou intéressant l’axe optique
TL;DR: Cette technique est interessante a integrer dans l’arsenal therapeutique de the chirurgie du pterygion dans les cas ou ces parametres sont peu perturbes.
5
Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management
Dhyna Thorel,Saskia Ingen-Housz-Oro,Daniel Benaïm,Vincent Daien,Eric E. Gabison,Valentine Saunier,Laurence Beral,David Touboul,Dominique Bremond-Gignac,Matthieu P. Robert,Robin Vasseur,G. Royer,Olivier Dereure,Brigitte Milpied,Claire Bernier,A. Welfringer-Morin,Christine Bodemer,Nadège Cordel,Marie Tauber,Carole Burillon,Marion Servant,C. Couret,B. Vabres,Florence Tetart,Myriam Cassagne,Marie-Ange Kuoch,Marc Muraine,Agnes Delcampe,Julie Gueudry +28 more
TL;DR: In this paper , the authors conducted a national audit of current practice in the 11 sites of the French reference center for toxic bullous dermatoses and a review of the literature to establish therapeutic consensus guidelines, and proposed an evaluation form to facilitate ophthalmic data collection in the chronic phase of EN and also proposed an algorithm for the ophthalmologic management of ocular sequelae.
[Dupilumab-related blepharoconjunctivitis: Recommendations of the CEDRE group. Atopic dermatitis, conjunctivitis and dupilumab: Which management approach?]
Serge Doan,Louis Arnould,Camille Febvay,Pierre Fournié,Julie Gueudry,Pierre Labalette,Coralie Ouilhon,Truc C. Tran,B. Vabres,Sébastien Barbarot,J. D. Bouaziz,Aurélie Du-Thanh,Marie Jachiet,Julien Seneschal,Angèle Soria,Delphine Staumont-Sallé,Christian Baudouin,Bruno Mortemousque +17 more
TL;DR: In this paper , the authors provide an overview of the status of this subject, to address the main questions raised by this type of conjunctivitis and to suggest a course of action for starting and continuing treatment with dupilumab in patients with AD, according to the recommendations of the French Ophthalmologist/Dermatologist group CEDRE.
4
Practice patterns in the management of bacterial keratitis: a five-continent survey
Simon Wespiser,Emilia Koestel,Thibaut Fabacher,Arnaud Sauer,Florent Aptel,Louis Arnould,Rimvydas Asoklis,Stéphanie Baillif,Christophe Baudouin,Pierre-Henri Becmeur,Diane Bernheim,Vincent Borderie,Nacim Bouheraoua,Jean-Louis Bourges,Alain M. Bron,Carole Burillon,Nicole Carnt,Christophe Chiquet,Béatrice Cochener,Isabelle Cochereau,Catherine Creuzot-Garcher,Thierry David,Paolo Fogagnolo,Lea Dormegny,Pierre Fournié,David Gaucher,Philippe Gohier,Gabrielle Gomart,Christina N Grupcheva,Julie Gueudry,Gaëlle Ho Wang Yin,Louis Hoffart,Saskia M Imhoff,Renata Iveković,Juliette Knoeri,Laurent Kodjikian,Julie Kosacki,Marc Labetoulle,Jean-Marc Legeais,Rafael Martínez-Costa,Arnaud Messerlin,Laurent Meyer,Nicolas Meyer,Harold Merle,Frédéric Mouriaux,Marc Muraine,Isabelle Orignac,Pierre-Jean Pisella,Giorgio L. Porro,Gilles Prévost,Siegfried G. Priglinger,H. Proust,Jean-Claude Quintyn,Philippe Riegel,Pierre-Yves Robert,Andres Rodriguez,Alejandro Rodríguez García,Dimitri Roels,Mathias Roth,Antoine Rousseau,Berthold Seitz,Leopoldo Spadea,Claude Speeg-Schatz,Darren Shu Jeng Ting,David Touboul,Marie Trone,B. Vabres,Lotte G Welinder,Robert Weiss,M. Ad. Wurtz,Tina Xirou,Tristan Bourcier +71 more
TL;DR: The results highlighting essential geographical disparities in the current management of bacterial keratitis over five continents highlight essential geographical disparities in the current management of bacterial keratitis.
3